Reuters logo
J&J quarterly sales rise 4.2 pct
October 18, 2016 / 10:51 AM / a year ago

J&J quarterly sales rise 4.2 pct

Oct 18 (Reuters) - Johnson & Johnson reported a 4.2 percent increase in quarterly revenue, fueled by strong sales in its prescription drugs business.

The company’s net earnings rose to $4.27 billion, or $1.53 per share, in the third quarter, from $3.36 billion, or $1.20 per share, a year earlier.

Sales rose to $17.82 billion from $17.10 billion.

Reporting by Natalie Grover in Bengaluru; Editing by Sriraj Kalluvila

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below